Alfonso Eirin
Impact in
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Genetics top 0.5%
- Mesenchymal stem cell research
Papers in
- Nephrology 34
- Chronic Kidney Disease and Diabetes 14
- Genetics 27
- Mesenchymal stem cell research 24
- Co-authors
- Lilach O. LermanAmir LermanXiang-Yang ZhuStephen C. TextorLaTonya J. HicksonJohn R. WoollardAndré J. van WijnenWeijun Huang
- Journals
- Hypertension (12 papers)American Journal of Physiology-Renal Physiology (11 papers)Stem Cell Research & Therapy (7 papers)Kidney International (7 papers)Nephrology Dialysis Transplantation (7 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Alfonso Eirin
160 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Nephrology 1.2k
- Genetics 1.1k
- Cancer Research 831
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 2.9k
Countries citing papers authored by Alfonso Eirin
This map shows the geographic impact of Alfonso Eirin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Eirin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Eirin more than expected).
Fields of papers citing papers by Alfonso Eirin
This network shows the impact of papers produced by Alfonso Eirin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Eirin. The network helps show where Alfonso Eirin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alfonso Eirin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 0 | |
| 8 | Cellular senescence: the good, the bad and the unknown Hit paper breakdown → | 2022 | 655 |
| 9 | 2021 | 13 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 49 | |
| 12 | 2019 | 6 | |
| 13 | 2019 | 44 | |
| 14 | 2018 | 84 | |
| 15 | 2018 | 18 | |
| 16 | 2017 | 264 | |
| 17 | 2014 | 37 | |
| 18 | 2013 | 87 | |
| 19 | 2012 | 52 | |
| 20 | 2011 | 49 |
About Alfonso Eirin
Alfonso Eirin is a scholar working on Nephrology, Genetics, Pulmonary and Respiratory Medicine, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 161 papers that have together received 6.3k indexed citations. Recurring topics across this work include Renal and Vascular Pathologies (72 papers), Extracellular vesicles in disease (29 papers), Mesenchymal stem cell research (24 papers), MicroRNA in disease regulation (18 papers), Cardiovascular Disease and Adiposity (16 papers), Aortic aneurysm repair treatments (16 papers), Chronic Kidney Disease and Diabetes (14 papers) and MRI in cancer diagnosis (12 papers). The work is most often cited by research in Nephrology (1.2k citations), Genetics (1.1k citations), Cancer Research (831 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (2.9k citations). Alfonso Eirin has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lilach O. Lerman, Amir Lerman, Xiang-Yang Zhu, Stephen C. Textor, LaTonya J. Hickson, John R. Woollard, André J. van Wijnen, Weijun Huang, James L. Kirkland and Hui Tang. Their work appears in journals such as Hypertension, American Journal of Physiology-Renal Physiology, Stem Cell Research & Therapy, Kidney International and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.